|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/26 | |
| C07K 14/605 |
| (11) | Patento numeris | 2934566 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13810957.4 |
| Europos patento paraiškos padavimo data | 2013-12-19 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-10-28 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-06-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2013/077307 |
| Data | 2013-12-19 |
| (87) | Numeris | WO 2014/096145 |
| Data | 2014-06-26 |
| (30) | Numeris | Data | Šalis |
| 12306647 | 2012-12-21 | EP |
| (72) |
HAACK, Torsten, DE
WAGNER, Michael, DE
HENKEL, Bernd, DE
STENGELIN, Siegfried, DE
EVERS, Andreas, DE
LORENZ, Martin, DE
LORENZ, Katrin, DE
|
| (73) |
SANOFI,
54, rue La Boétie, 75008 Paris,
FR
|
| (54) | EXENDIN-4 DERIVATIVES AS DUAL GLP1/GIP OR TRIGONAL GLP1/GIP/GLUCAGON AGONISTS |
| EXENDIN-4 DERIVATIVES AS DUAL GLP1/GIP OR TRIGONAL GLP1/GIP/GLUCAGON AGONISTS |